BeOne Medicines Ltd.
BEIGF
$22.51
$6.5641.13%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.32B | 1.12B | 1.19B | 1.03B | 929.17M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.32B | 1.12B | 1.19B | 1.03B | 929.17M |
| Cost of Revenue | 689.50M | 165.00M | 173.02M | 171.56M | 592.60M |
| Gross Profit | 625.80M | 952.28M | 1.02B | 854.56M | 336.57M |
| SG&A Expenses | 537.91M | 459.29M | 531.28M | 472.48M | 443.73M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -1.26M | 1.28M | -- |
| Total Operating Expenses | 1.23B | 1.11B | 1.26B | 1.17B | 1.04B |
| Operating Income | 87.89M | 11.10M | -75.01M | -142.60M | -107.16M |
| Income Before Tax | 99.55M | 20.90M | -65.63M | -134.22M | -105.92M |
| Income Tax Expenses | 5.23M | 19.63M | 74.06M | 16.70M | 14.49M |
| Earnings from Continuing Operations | 94.32M | 1.27M | -139.70M | -150.92M | -120.41M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 94.32M | 1.27M | -139.70M | -150.92M | -120.41M |
| EBIT | 87.89M | 11.10M | -75.01M | -142.60M | -107.16M |
| EBITDA | 117.75M | 42.73M | -33.25M | -119.32M | -83.41M |
| EPS Basic | 11.32 | 0.15 | -17.09 | -18.69 | -14.95 |
| Normalized Basic EPS | 0.59 | 0.13 | -0.38 | -0.77 | -0.63 |
| EPS Diluted | 10.14 | 0.15 | -17.09 | -18.69 | -15.21 |
| Normalized Diluted EPS | 0.57 | 0.13 | -0.38 | -0.77 | -0.63 |
| Average Basic Shares Outstanding | 108.32M | 106.93M | 106.26M | 104.97M | 104.70M |
| Average Diluted Shares Outstanding | 8.66M | 8.55M | 8.17M | 8.07M | 8.05M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -9.60% | -- |